Arcus Biosciences, Inc. (RCUS) ownership: Top institutional holder: GILEAD SCIENCES, INC. ($678.77M). Insider activity: Net Seller (0 buys, 2 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| GILEAD SCIENCES, INC. | 31424760.00 | $678.77M | 2026-03-31 |
| BlackRock, Inc. | 15226475.00 | $328.89M | 2026-03-31 |
| VANGUARD GROUP INC | 7962874.00 | $189.76M | 2025-12-31 |
| WELLINGTON MANAGEMENT GROUP LLP | 6089516.00 | $131.53M | 2026-03-31 |
| STATE STREET CORP | 5412901.00 | $116.92M | 2026-03-31 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5030993.00 | $108.67M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4272056.00 | $92.28M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3856725.00 | $83.31M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-11 | |
| Sell | null | 2025-12-16 |
Back to RCUS overview · RCUS earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.